Literature DB >> 9502252

Sleep patterns after carbachol delivery in the ventral oral pontine tegmentum of the cat.

M Garzón1, I De Andrés, F Reinoso-Suárez.   

Abstract

This study examines dose-related effects on sleep produced by low-volume and low-dose carbachol microinjections in the ventral part of the cat nucleus reticularis pontis oralis. Carbachol microinjections (0.04, 0.08, 0.8 or 4 microg; volume 20 nl) in this location triggered paradoxical sleep with a very short dose-unrelated latency. The four carbachol doses effectively generated all the polygraphic and behavioral signs of paradoxical sleep when microinjected at any level within the ventral part of the nucleus reticularis pontis oralis (AP 0.5 to -3.5, L 0.5-3.5, V 3.5-5.0, on the Reinoso-Suárez atlas [Topographischer Hirnatlas der Katze (1961); Merck, Darmstadt]). The dose-related increase of total paradoxical sleep time was due to the increase in both the duration and number of paradoxical sleep episodes. This paradoxical sleep increase was associated with a dose-related decrease in the amount of time spent in both slow wave sleep and drowsiness, but not with any decrease in total wakefulness. The lengthening of the latency to slow wave sleep onset was dose related. These results show that the ventral oral pontine tegmentum is a very sensitive site for the induction and maintenance of paradoxical sleep.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9502252     DOI: 10.1016/s0306-4522(97)00494-6

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  16 in total

1.  A quantitative study of the brainstem cholinergic projections to the ventral part of the oral pontine reticular nucleus (REM sleep induction site) in the cat.

Authors:  Margarita Lucía Rodrigo-Angulo; Elisia Rodríguez-Veiga; Fernando Reinoso-Suárez
Journal:  Exp Brain Res       Date:  2004-09-10       Impact factor: 1.972

2.  Dynamics of neuron spike activity in the oral nucleus of the pons during the sleep-waking cycle in cats.

Authors:  O Yu Dergacheva; I E Khachikova; A A Burikov
Journal:  Neurosci Behav Physiol       Date:  2004-06

Review 3.  Brainstem mechanisms of paradoxical (REM) sleep generation.

Authors:  Pierre-Hervé Luppi; Olivier Clement; Emilie Sapin; Christelle Peyron; Damien Gervasoni; Lucienne Léger; Patrice Fort
Journal:  Pflugers Arch       Date:  2011-11-15       Impact factor: 3.657

4.  Eye movements and abducens motoneuron behavior after cholinergic activation of the nucleus reticularis pontis caudalis.

Authors:  Javier Márquez-Ruiz; Miguel Escudero
Journal:  Sleep       Date:  2010-11       Impact factor: 5.849

5.  Eye movements and abducens motoneuron behavior during cholinergically induced REM sleep.

Authors:  Javier Márquez-Ruiz; Miguel Escudero
Journal:  Sleep       Date:  2009-04       Impact factor: 5.849

6.  A restricted parabrachial pontine region is active during non-rapid eye movement sleep.

Authors:  P Torterolo; S Sampogna; M H Chase
Journal:  Neuroscience       Date:  2011-06-15       Impact factor: 3.590

7.  c-Fos expression in GABAergic, serotonergic, and other neurons of the pontomedullary reticular formation and raphe after paradoxical sleep deprivation and recovery.

Authors:  K J Maloney; L Mainville; B E Jones
Journal:  J Neurosci       Date:  2000-06-15       Impact factor: 6.167

8.  Cholinergic Oculomotor Nucleus Activity Is Induced by REM Sleep Deprivation Negatively Impacting on Cognition.

Authors:  Patrícia Dos Santos; Adriano D S Targa; Ana Carolina D Noseda; Lais S Rodrigues; Juliane Fagotti; Marcelo M S Lima
Journal:  Mol Neurobiol       Date:  2016-09-22       Impact factor: 5.590

9.  Hypocretinergic and non-hypocretinergic projections from the hypothalamus to the REM sleep executive area of the pons.

Authors:  Pablo Torterolo; Sharon Sampogna; Michael H Chase
Journal:  Brain Res       Date:  2012-10-30       Impact factor: 3.252

10.  Hypocretin/Orexin neuropeptides: participation in the control of sleep-wakefulness cycle and energy homeostasis.

Authors:  A Nuñez; M L Rodrigo-Angulo; I De Andrés; M Garzón
Journal:  Curr Neuropharmacol       Date:  2009-03       Impact factor: 7.363

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.